Axsome Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 4.16 M | $760.66 M | -0.38% | 8.33% |
| BLACKROCK, INC. | 02/12/2026 | 3.91 M | $714.77 M | 3.23% | 7.82% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 1.51 M | $275.76 M | 45.54% | 3.02% |
| INVESCO LTD. | 02/19/2026 | 1.27 M | $232.59 M | 28.56% | 2.55% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 1.22 M | $223.12 M | -8.46% | 2.44% |
| FMR LLC | 02/17/2026 | 1.18 M | $215.81 M | 27.35% | 2.36% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 1.15 M | $210.04 M | 27.78% | 2.30% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.01 M | $184.54 M | 1.26% | 2.02% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 989.45 K | $180.71 M | 100.00% | 1.98% |
| STATE STREET CORP | 02/13/2026 | 958.15 K | $175.00 M | 1.61% | 1.92% |
| RTW INVESTMENTS, LP | 02/17/2026 | 888.00 K | $162.18 M | -20.64% | 1.78% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 02/11/2026 | 668.71 K | $122.13 M | -0.32% | 1.34% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 618.03 K | $112.88 M | 71.08% | 1.24% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 571.23 K | $104.20 M | -23.47% | 1.14% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 549.11 K | $100.29 M | 85.33% | 1.10% |
| NORGES BANK | 02/10/2026 | 495.46 K | $90.49 M | 100.00% | 0.99% |
| MORGAN STANLEY | 02/13/2026 | 491.20 K | $89.71 M | 19.93% | 0.98% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 467.98 K | $85.47 M | 58.76% | 0.94% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 436.06 K | $79.64 M | 20.41% | 0.87% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 402.70 K | $73.55 M | 5.41% | 0.81% |
| NORTHERN TRUST CORP | 02/17/2026 | 390.43 K | $71.31 M | -4.66% | 0.78% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 367.58 K | $67.13 M | -17.40% | 0.73% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/17/2026 | 366.18 K | $66.88 M | 1.73% | 0.73% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 363.11 K | $66.32 M | -1.44% | 0.73% |
| UBS GROUP AG | 01/29/2026 | 355.32 K | $64.90 M | 67.25% | 0.71% |
| NUVEEN, LLC | 02/12/2026 | 349.21 K | $63.78 M | 17.05% | 0.70% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 342.57 K | $62.57 M | 19.95% | 0.68% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 325.44 K | $59.44 M | -0.06% | 0.65% |
| MARSHALL WACE, LLP | 02/13/2026 | 320.57 K | $58.55 M | -15.20% | 0.64% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 315.39 K | $57.60 M | -4.46% | 0.63% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 311.90 K | $56.97 M | 9.44% | 0.62% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 304.39 K | $55.59 M | 60.11% | 0.61% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 300.91 K | $54.96 M | 34.25% | 0.60% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 279.40 K | $51.03 M | 2.27% | 0.56% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 02/11/2026 | 278.84 K | $50.93 M | -14.55% | 0.56% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 255.10 K | $46.59 M | 0.72% | 0.51% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 253.12 K | $46.23 M | -52.40% | 0.51% |
| PFM HEALTH SCIENCES, LP | 02/17/2026 | 251.56 K | $45.95 M | -52.57% | 0.50% |
| JPMORGAN CHASE & CO | 02/11/2026 | 233.19 K | $42.59 M | -6.91% | 0.47% |
| MAN GROUP PLC | 02/17/2026 | 228.64 K | $41.76 M | -20.59% | 0.46% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 220.52 K | $40.28 M | -1.29% | 0.44% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 210.00 K | $38.35 M | 40.00% | 0.42% |
| FIRST TURN MANAGEMENT, LLC | 02/13/2026 | 206.92 K | $37.79 M | 35.58% | 0.41% |
| CITIGROUP INC | 02/13/2026 | 204.10 K | $37.28 M | 43.72% | 0.41% |
| TRI LOCUM PARTNERS LP | 02/17/2026 | 201.63 K | $36.83 M | -30.98% | 0.40% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 188.50 K | $34.43 M | 100.00% | 0.38% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 188.26 K | $34.38 M | -9.95% | 0.38% |
| CITADEL ADVISORS LLC | 02/17/2026 | 176.00 K | $32.14 M | 94.05% | 0.35% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/12/2026 | 173.30 K | $31.65 M | 51.95% | 0.35% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 170.00 K | $31.05 M | 13.33% | 0.34% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Axsome Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 517 institutional investors and hedge funds held shares of Axsome Therapeutics Inc. The most heavily invested institutionals were:
Invesco Ltd.: 1.3 M
Assenagon Asset Management S.A.: 865,958
UBS Group AG: 547,195
Pictet Asset Management Holding SA: 415,983
PRINCIPAL FINANCIAL GROUP INC: 350,488
Nuveen, LLC: 335,737
75.24% of Axsome Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 47.15 M shares in the last 24 months. This purchase volume represents approximately $7.76 B in transactions.